Broadly neutralizing monoclonal antibody (3BNC117-LS/teropavimab) that binds the CD4-binding site on HIV-1 Env gp120, preventing attachment to CD4 and viral entry; its Fc domain mediates effector functions (e.g., ADCC and ADCP, and potentially CDC) to promote clearance of virions and infected cells.